Sort   by:  
 Page size 
Transcription was assessed in the human H358 NSCLC cell line after knockdown of BRG1, one of the mutually exclusive subunits of the SWI/SNF chromatin remodeling complex, by 2 different shRNAs. One biolgical replicate of each treatment; 4 technical replicates of each treatment.
ORGANISM(S): Homo sapiens 
Human kinome CRISPR knockout screen in H358 parental and sotorasib resistant H358 cells
We showed that the over-expression of the SR protein SRSF2 led to the regulation of transcript abundance of many genes. H358 cell line with 6 samples with SRSF2 over-expression and 6 samples as control.
ORGANISM(S): Homo sapiens 
Human lung cancer cell lines A549 and H358 were obtained from (Biobank of Medical University of Graz) and cultured in RPMI 1640 (R0883; Sigma) supplemented with 10% fetal bovine serum (FBS; Gibco), 5 mM glutamine and 5 mM Pen Step, and sub-cultured regularly. For siRNA mediated knock-down of GAPDH, ...
ORGANISM(S): Homo sapiens (Human) 
2025-05-12 | PXD061610 | Pride
A human kinome CRISPR knockout screen in H358 parental and sotorasib-R H358 cells using Addgene pooled libraries (#75314).
ORGANISM(S): Homo sapiens 
2025-10-07 | GSE275314 | GEO
ATAC-seq of NCI-H358 cells treated with KRAS G12C inhibitor sotorasib
NCI-H358 is a KRAS G12C-mutant non-small lung cancer cell line known to be sensitive to KRAS G12C-inhibitor sotorasib. Here, we aimed to develop sotorasib resistance in H358 and interrogate the resulting sotorasib-resistant cell line (H358-R). The H358-R cell line was created by continuous culturing...
ORGANISM(S): Homo sapiens 
2025-09-24 | GSE277630 | GEO
Epithelial-mesenchymal transition has been implicated in tumor metastasis, cancer drug resistance and cancer stem cell features. In this study, we examined gene expression profiles of three non-small cell lung cancer cell lines, before and after experimentally induced EMT. We modeled epitheial-mese...
ORGANISM(S): Homo sapiens 
Expression data from CHST11 over-expression in A-549 or NCI-H358 cells
ATAC-seq of sotorasib-resistant H23 and H358 cells treated with TEAD inhibitor GNE-7883
Sort   by:  
 Page size